Celofem 2.5mg Tablet

About

Celofem 2.5mg Tablet is an aromatase inhibitor, a class of medications primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. Its mechanism of action involves selectively inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. By blocking this enzyme, Celofem significantly reduces the levels of estrogen circulating in the body. Since many breast cancers are estrogen-dependent, lowering estrogen levels can effectively slow down or stop the growth of these cancer cells, thereby preventing disease progression or recurrence.

This medication is particularly effective in postmenopausal women because their primary source of estrogen is peripheral conversion rather than ovarian production. It is often used as adjuvant therapy after surgery, as extended adjuvant therapy, or for the first-line treatment of advanced breast cancer. Regular monitoring for bone density and lipid profiles is important during treatment, as estrogen deprivation can have systemic effects. Patients should be counselled on potential side effects and the importance of adherence to therapy.

Uses

• Adjuvant treatment of early breast cancer
• Extended adjuvant treatment of breast cancer
• First-line treatment of advanced breast cancer
• Treatment of advanced breast cancer after anti-estrogen therapy

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your doctor.

Benefits

• Significantly reduces estrogen levels
• Effective in hormone-receptor-positive breast cancer
• Reduces the risk of cancer recurrence
• Improves disease-free survival
• Oral administration for convenience
• Well-established efficacy in postmenopausal women

Side Effects

• Hot flashes
• Joint pain (arthralgia)
• Fatigue
• Nausea
• Headache
• Bone thinning (osteoporosis)
• Hair thinning
• Vaginal dryness
• Elevated cholesterol levels
• Mood changes
• Insomnia
• Peripheral edema

Safety Measures

• Alcohol - Moderate alcohol intake is generally acceptable, but excessive use may exacerbate liver strain or hot flashes.
• Pregnancy - Celofem is contraindicated in premenopausal women and during pregnancy due to potential harm to the fetus.
• Breastfeeding - Not recommended during breastfeeding as the drug's effects on the infant are unknown.
• Liver - Use with caution in patients with severe liver impairment; dose adjustment may be necessary.
• Kidney - Generally no dose adjustment is needed for kidney impairment, but monitor in severe cases.
• Lung - No specific lung concerns, but monitor for general adverse reactions and report any new respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.